Scarica l'app Stockscreener
1.25
2.34%
-0.03
Dopo l'orario di chiusura:
1.25
Promis Neurosciences Inc Borsa (PMN) Ultime notizie
ProMIS Neurosciences (NASDAQ:PMN) versus Rigel Pharmaceuticals (NASDAQ:RIGL) Head-To-Head Analysis - Defense World
ProMIS Neurosciences And 2 Other Stocks Under $5 Executives Are Buying - MSN
ProMIS Neurosciences, Inc. (NASDAQ:PMN) Director Madge K. Shafmaster Acquires 60,000 Shares - Defense World
Director Madge Shafmaster Acquires 200,000 Shares of ProMIS Neur - GuruFocus.com
ProMIS Neurosciences, Inc. (NASDAQ:PMN) Director Buys $89,600.00 in Stock - Defense World
ProMIS Neurosciences director Shafmaster purchases $255,750 in stock By Investing.com - Investing.com South Africa
ProMIS Neurosciences director Shafmaster purchases $255,750 in stock By Investing.com - Investing.com Australia
ProMIS Neurosciences director Shafmaster purchases $255,750 in stock - Investing.com
ProMIS Neurosciences director Shafmaster purchases $255,750 in stock By Investing.com - Investing.com Canada
ProMIS Neurosciences (NASDAQ:PMN) versus Regulus Therapeutics (NASDAQ:RGLS) Critical Contrast - Defense World
BSE SME Popular Foundation slips on debut - Business Standard
Popular Foundations shares list at IPO price on BSE SME platform - The Economic Times
Popular Foundations makes tepid debut, shares list flat at ₹37 apiece on BSE SME platform - Upstox
How To Check Popular Foundations IPO Allotment Status - NDTV Profit
Taking a look at what insiders are doing to gauge the PureCycle Technologies Inc (PCT)’s direction - Knox Daily
ProMIS Neurosciences And 2 Other Stocks Under $5 Executives Are Buying - Benzinga
Popular Foundations IPO allotment to be finalized today - IPO Watch
Prosperity Bancshares, Inc. (NYSE:PB) Shares Bought by Federated Hermes Inc. - Defense World
The Psychology of PureCycle Technologies Inc Inc. (PCT) Price Performance: Understanding Market Sentiment - The InvestChronicle
ProMIS Neurosciences to Showcase PMN310’s Ability to Target - GlobeNewswire
ProMIS unveils promising Alzheimer's antibody data at ICBN By Investing.com - Investing.com Australia
ProMIS unveils promising Alzheimer's antibody data at ICBN - Investing.com India
Pre-market Movers: TNON, FULC, SMFL, RYDE, NTGR… - RTTNews
ProMIS unveils promising Alzheimer's antibody data at ICBN By Investing.com - Investing.com Canada
ProMIS unveils promising Alzheimer's antibody data at ICBN - Investing.com
ProMIS Neurosciences (NASDAQ:PMN) Trading Down 5% - Defense World
ProMIS Neurosciences to Present at the H.C. Wainwright 26th Annual Global Investment Conference - GlobeNewswire
ProMIS Neurosciences to Present at the H.C. Wainwright 26th Annual Global Investment Conference - StockTitan
ProMIS Neurosciences to Present at the H.C. Wainwright 26th Annual Global Investment Conference - Yahoo Finance
Around $2M Bet On This Health Care Stock? Check Out These 3 Stocks Under $5 Insiders Are Aggressively Buying - Benzinga
Patrick D. Kirwin Buys 10,000 Shares of ProMIS Neurosciences, Inc. (NASDAQ:PMN) Stock - Defense World
Origin Energy Limited (OGFGY) to Issue Dividend of $0.15 on October 11th - Defense World
Dominion Lending Centres Inc. (DLC) To Go Ex-Dividend on August 30th - Defense World
Promis Neurosciences director buys $12,492 in company stock By Investing.com - Investing.com Canada
Promis Neurosciences director buys $12,492 in company stock - Investing.com India
Promis Neurosciences director buys $12,492 in company stock By Investing.com - Investing.com Australia
Promis Neurosciences director buys $12,492 in company stock - Investing.com
Why Ainos Shares Are Trading Higher By Around 38%; Here Are 20 Stocks Moving Premarket - Benzinga
PMN Stock Earnings: ProMIS Neurosciences Beats EPS for Q2 2024 - MSN
ProMIS Neurosciences Announces Second Quarter 2024 Financial Results and Recent Highlights - GlobeNewswire
ProMIS Neurosciences Announces Second Quarter 2024 Financial Results and Recent Highlights - StockTitan
PMNProMIS Neurosciences, Inc. Latest Stock News & Market Updates - StockTitan
ProMIS Neurosciences Announces Data on the Pathogenic Role - GlobeNewswire
ProMIS Neurosciences Announces Data on the Pathogenic Role of Toxic Misfolded SOD1 Aggregates in ALS Published in Acta Neuropathologica and Open Biology - StockTitan
ProMIS Neurosciences insider purchases shares worth over $1 million - Investing.com
ProMIS Neurosciences insider purchases shares worth over $1 million - Investing.com India
ProMIS Neurosciences insider purchases shares worth over $1 million By Investing.com - Investing.com Canada
Promis Neurosciences insider acquires over $1 million in shares - Investing.com
Promis Neurosciences insider acquires shares worth $1.5m By Investing.com - Investing.com Canada
Promis Neurosciences insider acquires shares worth $1.5m - Investing.com
Promis Neurosciences insider acquires shares worth $1.5m By Investing.com - Investing.com UK
ProMIS Neurosciences to Participate in BTIG Virtual Biotechnology Conference 2024 - GlobeNewswire
FY2024 EPS Estimates for ProMIS Neurosciences, Inc. Raised by Leede Jones Gab (NASDAQ:PMN) - Defense World
ProMIS Neurosciences to Participate in BTIG Virtual Biotechnology Conference 2024 - Financial Post
ProMIS Neurosciences to Participate in BTIG Virtual Biotechnology Conference 2024 - StockTitan
ProMIS Neurosciences Showcases Novel Vaccine Approach for - GlobeNewswire
ProMIS Neurosciences Showcases Novel Vaccine Approach for Maximal Targeting of Toxic Amyloid-Beta Oligomers at the 2024 Alzheimer’s Association International Conference - StockTitan
ProMIS Neurosciences regains NASDAQ compliance By Investing.com - Investing.com Nigeria
ProMIS Neurosciences regains NASDAQ compliance - Investing.com
Post-Trade Analysis: ProMIS Neurosciences Inc. (PMN) Slides -20.70, Closing at 1.60 - The Dwinnex
0.05%
4.86%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Capitalizzazione:
|
Volume (24 ore):